Indi (Integrated Dx)

Xpresys Lung is a molecular blood test developed to provide non-invasive, objective information for assessment of pulmonary nodules.

[Indi (Integrated Dx) @IntegratedDx]

In Tough Diagnostics World, Will Ruling Out Cancer Be Good Business? | in depth Xconomy column by @AlexLash http://t.co/0UYYVqV5Ng

[Indi (Integrated Dx) @IntegratedDx]

Today CHEST Physician published a story about our recent study of benign lung nodules http://t.co/5Dn7znTVjI

[Indi (Integrated Dx) @IntegratedDx]

New Indi landmark study in CHEST suggests there may be overtreatment of benign lung nodules http://t.co/TE6HPiZ0xg

[Indi (Integrated Dx) @IntegratedDx]

Indi Publishes Technical Paper on Methods to Improve Reproducibility and Robustness of MRM-Mass Spec Proteomic Tests http://t.co/5HJeNOaKq9

[Indi (Integrated Dx) @IntegratedDx]

"A very elegant approach" Indi Publishes Details of Assay Variability Controls Used in Xpresys Lung | GenomeWeb http://t.co/OQrXPP7Sn2

[Indi (Integrated Dx) @IntegratedDx]

Indi Announces Agreement to License Xpresys Lung in Canada to Caprion | http://t.co/OXeqV2OVQB | cc:@CaprionProteome

[Indi (Integrated Dx) @IntegratedDx]

Landmark Indi Publication Shows Xpresys Lung Helps Identify Benign Lung Nodules |http://t.co/IBgHrjy5fX

[Ben Fidler @BentheFidler]

In Short Order, Indi Convinces Insurers To Cover Its Lung Test http://t.co/3VIpQUskN0 by @alexlash @IntegratedDx

[Indi (Integrated Dx) @IntegratedDx]

Indi Secures Contracts for Xpresys Lung with MultiPlan and Five Other PPOs | Release | http://t.co/6L6oFeI9SM

[Indi (Integrated Dx) @IntegratedDx]

Blood Test for Pulmonary Nodules Now Available to 200 Million Covered Lives | Release | http://t.co/eDa2QZAwoy

[Indi (Integrated Dx) @IntegratedDx]

Come meet Dr. Alexander Porter at #Chest2014 Booth 1731 and learn more about Xpresys Lung http://t.co/TfHVLGIiCG #LungCancer

[Indi (Integrated Dx) @IntegratedDx]

Xpresys Lung has only one complication, a bandage. Learn more at #Chest2014 Booth 1731 http://t.co/TfHVLGIiCG #LungCancer

[Indi (Integrated Dx) @IntegratedDx]

If you're heading to Life Science Innovation Northwest 2014 @Washbio - come hear @IntegratedDx CEO Dr. Al Luderer speak this Friday |...

[Indi (Integrated Dx) @IntegratedDx]

Wondering how to build a sustainable Dx company? Come hear Indi CEO Dr. Al Luderer speak at #BIO2014 http://t.co/blAV1NXoHm

[Indi (Integrated Dx) @IntegratedDx]

Headed to #ATS2014? Come hear presentations on Xpresys Lung and Lung Nodule Management. http://t.co/RIuPcVQklF #proteomics #lungcancer

[Indi (Integrated Dx) @IntegratedDx]

Indi Raises $47 Million for Dx to Help Doctors Better Assess Lung Nodules | Release | http://t.co/385CU9jqhO #proteomics

[Indi (Integrated Dx) @IntegratedDx]

Indi Raises $47 Million for Dx to Help Doctors Better Assess Lung Nodules | http://t.co/385CU9jqhO #diagnostics #proteomics #lungcancer

[Indi (Integrated Dx) @IntegratedDx]

At MSACL 2014, Advances in MS-based Clinical Proteomics...Starting with Xpresys Lung | @ProteoMonitor | #Proteomics | GenomeWeb...

[Indi (Integrated Dx) @IntegratedDx]

Heading to Leerink Global Healthcare 2014? Come hear about the next blockbuster diagnostic from Indi's CEO, Al Luderer.

[Indi (Integrated Dx) @IntegratedDx]

Cancer Genomics Enters a New Era | @ISBLeeHood in GEN mag on Blood-based Dx and Xpresys Lung | http://t.co/6GJOQsgVUw